Thesis Care raises $45M
Thesis Care announced a Series A round of $45M on 26 March 2026. The company operates in HealthTech and is based in United States. It was founded by Niren Gandra, M.D., CEO & Co-Founder.
Founder
Niren Gandra, M.D.
CEO & Co-Founder, Thesis Care
Outreach angles
- -Thesis Care deploys clinical AI agents backed by human clinicians for care management and clinical operations, creating a hybrid model that addresses both AI reliability concerns and staffing shortages.
- -The $45M Series A led by Oak HC/FT, one of healthcare's most specialized venture funds, provides strong validation that Thesis Care's hybrid AI-human clinical operations model has enterprise traction.
- -By targeting care management and clinical operations rather than direct patient care, Thesis Care avoids the highest-risk regulatory hurdles while attacking the most operationally expensive parts of healthcare delivery.
Signals
Series AAI-NativeHealthcareEnterprise
Round details
Company: Thesis Care
Domain: thesis.care
Amount: $45M
Stage: Series A
Industry: HealthTech
Country: United States
Announced: 26 March 2026
Other HealthTech raises
Recently funded in United States